That treatment with CFTR correctors, i.e., VX-809 and TMA, compounds that increase the amount of functional CFTR on the cell surface, partially restores mitochondrial function in CF cells strongly suggests that there are interaction dynamics between CFTR, mitochondrial (patho)physiology, and ROS [31]. The gene discussed is CFTR; the disease is cystic fibrosis.